Human STING is a proton channel.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
04 08 2023
Historique:
medline: 7 8 2023
pubmed: 3 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

Proton leakage from organelles is a common signal for noncanonical light chain 3B (LC3B) lipidation and inflammasome activation, processes induced upon stimulator of interferon genes (STING) activation. On the basis of structural analysis, we hypothesized that human STING is a proton channel. Indeed, we found that STING activation induced a pH increase in the Golgi and that STING reconstituted in liposomes enabled transmembrane proton transport. Compound 53 (C53), a STING agonist that binds the putative channel interface, blocked STING-induced proton flux in the Golgi and in liposomes. STING-induced LC3B lipidation and inflammasome activation were also inhibited by C53, suggesting that STING's channel activity is critical for these two processes. Thus, STING's interferon-induction function can be decoupled from its roles in LC3B lipidation and inflammasome activation.

Identifiants

pubmed: 37535724
doi: 10.1126/science.adf8974
doi:

Substances chimiques

Inflammasomes 0
Ion Channels 0
Liposomes 0
MAP1LC3B protein, human 0
Membrane Proteins 0
Microtubule-Associated Proteins 0
Protons 0
STING1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

508-514

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Bingxu Liu (B)

Broad Institute, Cambridge, MA, USA.
Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
The Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA.

Rebecca J Carlson (RJ)

Broad Institute, Cambridge, MA, USA.
Massachusetts Institute of Technology, Department of Health Sciences and Technology, Cambridge, MA, USA.

Ivan S Pires (IS)

The Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA.

Matteo Gentili (M)

Broad Institute, Cambridge, MA, USA.

Ellie Feng (E)

Broad Institute, Cambridge, MA, USA.
Massachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA.

Quentin Hellier (Q)

Broad Institute, Cambridge, MA, USA.

Marc A Schwartz (MA)

Broad Institute, Cambridge, MA, USA.
Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, USA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Paul C Blainey (PC)

Broad Institute, Cambridge, MA, USA.
The Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA.
Massachusetts Institute of Technology, Department of Biological Engineering, Cambridge, MA, USA.

Darrell J Irvine (DJ)

The Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA.

Nir Hacohen (N)

Broad Institute, Cambridge, MA, USA.
Massachusetts General Hospital Cancer Center, Boston, MA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH